Document is current
Any future updates will be listed below
-
Authors
Carollo, Massimo
Crisafulli, Salvatore
Zerio, Marta
Maccarrone, Francesco
Paladin, Anna
Selleri, Margherita
Forti, Anna
Mattace-Raso, Francesco U. S.
Trifirò, Gianluca https://orcid.org/0000-0003-1147-7296
-
Funding
Funding for this research was provided by:
Università degli Studi di Verona
- License Information
-
More Information
Article History
Received: 18 November 2025
Accepted: 12 March 2026
First Online: 8 April 2026
Declarations
:
: GT has served, over the last 3 years, on advisory boards/seminars funded by Sanofi, MSD, Alfa Sigma, Eli Lilly, Celgene, Daiichi Sankyo, Novo Nordisk, Gilead, and Amgen on topics not related to content of this paper; he is also a scientific coordinator of the academic spin-off “INSPIRE srl,” which has received funding in the last three years from several pharmaceutical companies (Kiowa Kirin, Shionogi, Shire, Novo Nordisk, and Daiichi Sankyo) for conducting observational studies and additional consultancy services on topics not related to the content of this paper. Additionally, he serves as a consultant for Viatris in a legal case related to an adverse reaction to sertraline. None of these listed activities is related to the topic of the article. The other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
: Not applicable.
: Not applicable.
: Not applicable.
: All supporting data are contained within the main text and supplementary materials.
: Not applicable.
: GT supervised the study and conceived the concept. MC, SC, MZ, FM, AP, MS, and AF conducted the first phases of the review (i.e., preliminary searches, study selection process, formal screening of search results against eligibility criteria, data extraction, and risk-of-bias assessment). MC wrote the first draft of the manuscript. SC, FMR, and GT critically revised the manuscript. All authors made important intellectual contributions and approved the manuscript for submission. The corresponding author (GT) attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
